Biolase Stock Performance
BIOL Stock | USD 0.19 0.03 18.75% |
The firm shows a Beta (market volatility) of 5.4, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BIOLASE will likely underperform. BIOLASE has an expected return of -1.92%. Please make sure to confirm BIOLASE information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to decide if BIOLASE performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Low | High |
Very Weak
Over the last 90 days BIOLASE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in April 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
Last Split Factor 1:100 | Dividend Date 2018-05-11 | Ex Dividend Date 2005-06-24 | Last Split Date 2023-07-28 |
1 | BIOLASE Upgraded at StockNews.com | 01/04/2024 |
2 | Purchase by Schuler Jack W of 8002 shares of BIOLASE | 01/23/2024 |
3 | BIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders Equity Continued Listing Requirement | 02/14/2024 |
4 | BIOLASE, Inc. Announces Closing of 7.0 Million Public Offering | 02/15/2024 |
5 | Biolase Announces First Quarter 2024 Webinar Series Lets Talk Dental | 02/20/2024 |
6 | StockNews.com Begins Coverage on BIOLASE | 02/26/2024 |
7 | Biolase faces Nasdaq delisting over share price rule By Investing.com - Investing.com Australia | 03/05/2024 |
8 | BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024 | 03/14/2024 |
9 | Disposition of 1395 shares by Jonathan Lord of BIOLASE subject to Rule 16b-3 | 03/15/2024 |
10 | Biolase Reports Full-Year 2023 Results Expects Continued Revenue Growth In 2024 | 03/21/2024 |
11 | BIOL Stock Earnings Biolase Beats EPS, Misses Revenue for Q4 2023 | 03/22/2024 |
Begin Period Cash Flow | 4.2 M |
BIOLASE |
BIOLASE Relative Risk vs. Return Landscape
If you would invest 110.00 in BIOLASE on December 30, 2023 and sell it today you would lose (91.00) from holding BIOLASE or give up 82.73% of portfolio value over 90 days. BIOLASE is currently does not generate positive expected returns and assumes 11.552% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than BIOLASE, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
BIOLASE Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BIOLASE's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BIOLASE, and traders can use it to determine the average amount a BIOLASE's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1666
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | BIOL |
Estimated Market Risk
11.55 actual daily | 96 96% of assets are less volatile |
Expected Return
-1.92 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BIOLASE is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BIOLASE by adding BIOLASE to a well-diversified portfolio.
BIOLASE Fundamentals Growth
BIOLASE Stock prices reflect investors' perceptions of the future prospects and financial health of BIOLASE, and BIOLASE fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BIOLASE Stock performance.
Return On Equity | -6.03 | ||||
Return On Asset | -0.29 | ||||
Current Valuation | 15.07 M | ||||
Shares Outstanding | 19.2 M | ||||
Price To Earning | (7.23) X | ||||
Price To Book | 0.77 X | ||||
Price To Sales | 0.07 X | ||||
Revenue | 49.16 M | ||||
Gross Profit | 16.53 M | ||||
EBITDA | (15.14 M) | ||||
Net Income | (20.63 M) | ||||
Cash Per Share | 1.39 X | ||||
Debt To Equity | 1.07 % | ||||
Current Ratio | 2.46 X | ||||
Cash Flow From Operations | (14.09 M) | ||||
Earnings Per Share | (29.44) X | ||||
Total Asset | 35.1 M | ||||
Retained Earnings | (316.8 M) | ||||
Current Asset | 34.8 M | ||||
About BIOLASE Performance
To evaluate BIOLASE Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when BIOLASE generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare BIOLASE Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand BIOLASE market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents BIOLASE's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for 2024 | ||
Return On Capital Employed | (1.16) | (1.10) | |
Return On Assets | (0.59) | (0.62) | |
Return On Equity | 83.53 | 87.71 |
Things to note about BIOLASE performance evaluation
Checking the ongoing alerts about BIOLASE for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BIOLASE help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.BIOLASE generated a negative expected return over the last 90 days | |
BIOLASE has high historical volatility and very poor performance | |
BIOLASE has some characteristics of a very speculative penny stock | |
BIOLASE has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 49.16 M. Net Loss for the year was (20.63 M) with profit before overhead, payroll, taxes, and interest of 16.53 M. | |
BIOLASE currently holds about 9.96 M in cash with (14.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
BIOLASE has a frail financial position based on the latest SEC disclosures | |
Latest headline from investorplace.com: BIOL Stock Earnings Biolase Beats EPS, Misses Revenue for Q4 2023 |
- Analyzing BIOLASE's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BIOLASE's stock is overvalued or undervalued compared to its peers.
- Examining BIOLASE's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BIOLASE's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BIOLASE's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BIOLASE's stock. These opinions can provide insight into BIOLASE's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIOLASE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for BIOLASE Stock analysis
When running BIOLASE's price analysis, check to measure BIOLASE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIOLASE is operating at the current time. Most of BIOLASE's value examination focuses on studying past and present price action to predict the probability of BIOLASE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIOLASE's price. Additionally, you may evaluate how the addition of BIOLASE to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is BIOLASE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIOLASE. If investors know BIOLASE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIOLASE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (29.44) | Revenue Per Share 38.469 | Quarterly Revenue Growth (0.04) | Return On Assets (0.29) | Return On Equity (6.03) |
The market value of BIOLASE is measured differently than its book value, which is the value of BIOLASE that is recorded on the company's balance sheet. Investors also form their own opinion of BIOLASE's value that differs from its market value or its book value, called intrinsic value, which is BIOLASE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIOLASE's market value can be influenced by many factors that don't directly affect BIOLASE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIOLASE's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIOLASE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIOLASE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.